Brief: Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility
03/06/2026 11:02
BRIEF-Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility June 3 (Reuters) - Granules India Ltd GRAN.NS:
GRANULES - RECEIVES US FDA EIR WITH VOLUNTARY ACTION INDICATED FOR CHANTILLY FACILITY
GRANULES - FOUR FORM 483 OBSERVATIONS ISSUED DURING MARCH 30-APRIL 3, 2026 INSPECTION
Source text: ID:nNSE2qnM0s
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake